Last updated at 23 hours ago
Director
DIN: 08421631
Rakesh Onkarchand Katna is currently associated with 2 companies in various capacities such as Individual Promoter and Director. They serve as a Director at SPARKK LIFE SCIENCES PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08421631.Rakesh Onkarchand Katna is currently involved in 2 different roles. Their most recent position is with AXCER MOLECULAR IMAGING AND THERAPY PRIVATE LIMITED as a Director. The first company Rakesh Onkarchand Katna was appointed to as a director was SPARKK LIFE SCIENCES PRIVATE LIMITED. Rakesh Onkarchand Katna has a status of Deactivated. Please verify the details for any specific requirements or conditions.
Rakesh Onkarchand Katna is currently associated with 2 companies in various capacities such as Individual Promoter and Director. They serve as a Director at SPARKK LIFE SCIENCES PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08421631.Rakesh Onkarchand Katna is currently involved in 2 different roles. Their most recent position is with AXCER MOLECULAR IMAGING AND THERAPY PRIVATE LIMITED as a Director. The first company Rakesh Onkarchand Katna was appointed to as a director was SPARKK LIFE SCIENCES PRIVATE LIMITED. Rakesh Onkarchand Katna has a status of Deactivated. Please verify the details for any specific requirements or conditions.
4
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
1y 2m 7 Months Interval
Company Name | Designation | Date of Appointment |
---|---|---|
SPARKK LIFE SCIENCES PRIVATE LIMITED | Individual Promoter | 15-Apr-2019 |
SPARKK LIFE SCIENCES PRIVATE LIMITED | Director | 15-Apr-2019 |
AXCER MOLECULAR IMAGING AND THERAPY PRIVATE LIMITED | Director | 28-Apr-2021 |
AXCER MOLECULAR IMAGING AND THERAPY PRIVATE LIMITED | Individual Promoter | 28-Apr-2021 |